Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Spinal Neoplasms | 27 | 2024 | 708 | 3.690 |
Why?
|
Bone Neoplasms | 23 | 2024 | 2564 | 1.370 |
Why?
|
Drug-Eluting Stents | 5 | 2021 | 683 | 0.880 |
Why?
|
Fractures, Spontaneous | 7 | 2024 | 230 | 0.830 |
Why?
|
Sirolimus | 6 | 2021 | 1544 | 0.800 |
Why?
|
Cardiovascular Agents | 4 | 2021 | 851 | 0.800 |
Why?
|
Peripheral Arterial Disease | 9 | 2024 | 1311 | 0.790 |
Why?
|
Spinal Cord Compression | 3 | 2019 | 234 | 0.760 |
Why?
|
Coronary Artery Disease | 6 | 2024 | 6545 | 0.560 |
Why?
|
Epidural Abscess | 3 | 2023 | 95 | 0.490 |
Why?
|
Absorbable Implants | 4 | 2021 | 333 | 0.480 |
Why?
|
Coronary Restenosis | 3 | 2022 | 396 | 0.450 |
Why?
|
Postoperative Complications | 15 | 2021 | 15749 | 0.440 |
Why?
|
Angioplasty, Balloon | 3 | 2022 | 608 | 0.420 |
Why?
|
Soft Tissue Neoplasms | 4 | 2023 | 1163 | 0.420 |
Why?
|
Paclitaxel | 1 | 2019 | 1728 | 0.380 |
Why?
|
Spinal Fusion | 2 | 2019 | 1303 | 0.360 |
Why?
|
Sarcoma | 5 | 2018 | 1801 | 0.340 |
Why?
|
Limb Salvage | 2 | 2011 | 488 | 0.320 |
Why?
|
Stents | 2 | 2019 | 3213 | 0.320 |
Why?
|
Femoral Artery | 4 | 2022 | 811 | 0.320 |
Why?
|
Orthopedic Procedures | 5 | 2020 | 1280 | 0.310 |
Why?
|
Quality of Life | 7 | 2022 | 13462 | 0.310 |
Why?
|
MicroRNAs | 1 | 2024 | 3784 | 0.300 |
Why?
|
Chondrosarcoma | 2 | 2020 | 301 | 0.280 |
Why?
|
Femoral Neoplasms | 2 | 2017 | 85 | 0.270 |
Why?
|
Models, Molecular | 15 | 2008 | 5381 | 0.270 |
Why?
|
Retrospective Studies | 41 | 2024 | 81457 | 0.250 |
Why?
|
Salvage Therapy | 1 | 2011 | 1272 | 0.240 |
Why?
|
Algorithms | 8 | 2024 | 14061 | 0.230 |
Why?
|
Walking | 3 | 2022 | 1198 | 0.220 |
Why?
|
Middle Aged | 56 | 2024 | 222903 | 0.220 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2006 | 360 | 0.220 |
Why?
|
Liposarcoma, Myxoid | 1 | 2023 | 60 | 0.210 |
Why?
|
Treatment Outcome | 27 | 2023 | 65180 | 0.210 |
Why?
|
Humans | 98 | 2024 | 765734 | 0.210 |
Why?
|
Atherectomy, Coronary | 1 | 2022 | 137 | 0.200 |
Why?
|
Aged | 47 | 2024 | 171050 | 0.200 |
Why?
|
Palliative Care | 1 | 2017 | 3645 | 0.200 |
Why?
|
Antiviral Agents | 7 | 2008 | 3052 | 0.200 |
Why?
|
Extremities | 4 | 2023 | 869 | 0.200 |
Why?
|
Spine | 5 | 2020 | 1129 | 0.190 |
Why?
|
Molecular Weight | 2 | 2021 | 2163 | 0.190 |
Why?
|
Spinal Fractures | 2 | 2019 | 703 | 0.190 |
Why?
|
Liposarcoma | 1 | 2023 | 288 | 0.180 |
Why?
|
Hypoalbuminemia | 1 | 2021 | 90 | 0.180 |
Why?
|
Neurosurgical Procedures | 4 | 2019 | 2081 | 0.170 |
Why?
|
Neoplasm Recurrence, Local | 7 | 2022 | 9368 | 0.170 |
Why?
|
Intermittent Claudication | 2 | 2012 | 300 | 0.170 |
Why?
|
Male | 58 | 2024 | 363585 | 0.170 |
Why?
|
Flaviviridae | 3 | 2008 | 9 | 0.170 |
Why?
|
Prosthesis Design | 3 | 2021 | 2105 | 0.160 |
Why?
|
Female | 56 | 2024 | 395961 | 0.160 |
Why?
|
Lower Extremity | 5 | 2012 | 1226 | 0.160 |
Why?
|
Fracture Fixation, Internal | 2 | 2016 | 982 | 0.160 |
Why?
|
Prospective Studies | 15 | 2022 | 54795 | 0.150 |
Why?
|
Fibromatosis, Aggressive | 1 | 2020 | 125 | 0.150 |
Why?
|
Cervical Atlas | 1 | 2018 | 22 | 0.150 |
Why?
|
Iliac Artery | 1 | 2020 | 330 | 0.150 |
Why?
|
Atherectomy | 2 | 2021 | 47 | 0.150 |
Why?
|
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2018 | 115 | 0.150 |
Why?
|
Chondroblastoma | 1 | 2018 | 47 | 0.150 |
Why?
|
Lordosis | 1 | 2019 | 99 | 0.150 |
Why?
|
Genetic Markers | 1 | 2024 | 2601 | 0.150 |
Why?
|
Popliteal Artery | 2 | 2021 | 301 | 0.150 |
Why?
|
Purinergic P2Y Receptor Antagonists | 1 | 2020 | 284 | 0.150 |
Why?
|
Bone Diseases | 1 | 2021 | 411 | 0.150 |
Why?
|
Mutation, Missense | 2 | 2006 | 2586 | 0.140 |
Why?
|
Acute Coronary Syndrome | 2 | 2020 | 2184 | 0.140 |
Why?
|
Lumbosacral Region | 1 | 2019 | 295 | 0.140 |
Why?
|
Osteosarcoma | 2 | 2020 | 909 | 0.140 |
Why?
|
Platelet Aggregation | 1 | 2020 | 769 | 0.140 |
Why?
|
Humeral Head | 1 | 2017 | 41 | 0.140 |
Why?
|
Giant Cell Tumor of Bone | 1 | 2018 | 119 | 0.140 |
Why?
|
Prognosis | 14 | 2024 | 29899 | 0.140 |
Why?
|
Chemoprevention | 1 | 2019 | 327 | 0.140 |
Why?
|
Reoperation | 5 | 2018 | 4294 | 0.140 |
Why?
|
Nomograms | 2 | 2016 | 235 | 0.140 |
Why?
|
Lung Neoplasms | 6 | 2019 | 13448 | 0.140 |
Why?
|
Polymers | 2 | 2019 | 1621 | 0.140 |
Why?
|
Leg Bones | 1 | 2016 | 19 | 0.130 |
Why?
|
Adult | 38 | 2024 | 222974 | 0.130 |
Why?
|
Myocardial Revascularization | 1 | 2020 | 793 | 0.130 |
Why?
|
Muramidase | 2 | 2006 | 163 | 0.130 |
Why?
|
Biomedical Technology | 1 | 2019 | 210 | 0.130 |
Why?
|
Mobility Limitation | 1 | 2020 | 408 | 0.130 |
Why?
|
Equipment and Supplies | 1 | 2019 | 273 | 0.130 |
Why?
|
Humerus | 1 | 2018 | 272 | 0.130 |
Why?
|
Risk Factors | 18 | 2024 | 74831 | 0.130 |
Why?
|
Serum Albumin | 2 | 2017 | 676 | 0.130 |
Why?
|
Silicon | 2 | 2006 | 141 | 0.130 |
Why?
|
Alkaline Phosphatase | 1 | 2019 | 855 | 0.130 |
Why?
|
Amides | 3 | 2007 | 455 | 0.130 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2006 | 2941 | 0.120 |
Why?
|
Ligaments, Articular | 1 | 2018 | 306 | 0.120 |
Why?
|
RNA Viruses | 2 | 2007 | 109 | 0.120 |
Why?
|
Multiple Trauma | 1 | 2018 | 369 | 0.120 |
Why?
|
Injury Severity Score | 1 | 2019 | 1049 | 0.120 |
Why?
|
Survival Rate | 8 | 2024 | 12787 | 0.120 |
Why?
|
Computer Simulation | 8 | 2008 | 6252 | 0.120 |
Why?
|
Membranes, Artificial | 2 | 2006 | 362 | 0.120 |
Why?
|
Fractures, Bone | 2 | 2018 | 2040 | 0.120 |
Why?
|
Physical Endurance | 1 | 2017 | 368 | 0.120 |
Why?
|
Arthroplasty | 1 | 2017 | 306 | 0.110 |
Why?
|
Coronary Stenosis | 1 | 2020 | 800 | 0.110 |
Why?
|
Pelvic Bones | 1 | 2016 | 273 | 0.110 |
Why?
|
Survival Analysis | 7 | 2024 | 10069 | 0.110 |
Why?
|
Drug Delivery Systems | 3 | 2019 | 2207 | 0.110 |
Why?
|
Patient Selection | 4 | 2020 | 4254 | 0.110 |
Why?
|
Thymosin | 1 | 2013 | 47 | 0.110 |
Why?
|
Antitubercular Agents | 3 | 2007 | 1385 | 0.110 |
Why?
|
Orthopedics | 1 | 2022 | 900 | 0.110 |
Why?
|
Carcinoma, Renal Cell | 2 | 2020 | 3169 | 0.110 |
Why?
|
Severity of Illness Index | 5 | 2024 | 15883 | 0.110 |
Why?
|
Mortality | 3 | 2020 | 2904 | 0.100 |
Why?
|
Secondary Prevention | 1 | 2019 | 1472 | 0.100 |
Why?
|
Fractional Flow Reserve, Myocardial | 1 | 2017 | 345 | 0.100 |
Why?
|
Case-Control Studies | 4 | 2024 | 22224 | 0.100 |
Why?
|
Humeral Fractures | 1 | 2015 | 283 | 0.100 |
Why?
|
Diabetes Mellitus | 2 | 2024 | 5891 | 0.100 |
Why?
|
Femoral Fractures | 1 | 2016 | 375 | 0.100 |
Why?
|
Endothelium, Vascular | 1 | 2024 | 4423 | 0.100 |
Why?
|
Ankle Brachial Index | 1 | 2012 | 166 | 0.100 |
Why?
|
Kidney Neoplasms | 2 | 2020 | 4262 | 0.100 |
Why?
|
Antifungal Agents | 2 | 2007 | 769 | 0.090 |
Why?
|
Echocardiography, Three-Dimensional | 1 | 2017 | 611 | 0.090 |
Why?
|
Endothelial Cells | 1 | 2024 | 3584 | 0.090 |
Why?
|
Molecular Structure | 8 | 2007 | 1885 | 0.090 |
Why?
|
Chemotherapy, Cancer, Regional Perfusion | 1 | 2011 | 94 | 0.090 |
Why?
|
Internationality | 1 | 2017 | 1006 | 0.090 |
Why?
|
Health Status Indicators | 1 | 2016 | 966 | 0.090 |
Why?
|
Aged, 80 and over | 15 | 2021 | 59459 | 0.090 |
Why?
|
Awards and Prizes | 1 | 2015 | 364 | 0.090 |
Why?
|
Thoracic Vertebrae | 1 | 2015 | 613 | 0.090 |
Why?
|
Imidazoles | 2 | 2007 | 1163 | 0.090 |
Why?
|
Aortic Valve Stenosis | 1 | 2023 | 2023 | 0.090 |
Why?
|
Advisory Committees | 1 | 2015 | 796 | 0.090 |
Why?
|
Joint Instability | 1 | 2018 | 802 | 0.090 |
Why?
|
Leg | 1 | 2015 | 1080 | 0.090 |
Why?
|
Antineoplastic Agents | 5 | 2019 | 13639 | 0.090 |
Why?
|
Endovascular Procedures | 1 | 2024 | 2222 | 0.090 |
Why?
|
Models, Chemical | 3 | 2007 | 608 | 0.090 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2019 | 2056 | 0.080 |
Why?
|
Angioplasty | 1 | 2012 | 352 | 0.080 |
Why?
|
Neoplasm Metastasis | 5 | 2019 | 4885 | 0.080 |
Why?
|
RNA Helicases | 2 | 2007 | 144 | 0.080 |
Why?
|
Decision Support Techniques | 1 | 2020 | 2002 | 0.080 |
Why?
|
Pain Measurement | 2 | 2017 | 3559 | 0.080 |
Why?
|
Athletes | 1 | 2017 | 1162 | 0.080 |
Why?
|
Protein Precursors | 1 | 2013 | 1134 | 0.080 |
Why?
|
Blood Transfusion | 1 | 2016 | 1295 | 0.080 |
Why?
|
Surgical Wound Infection | 2 | 2016 | 1543 | 0.080 |
Why?
|
England | 2 | 2021 | 533 | 0.080 |
Why?
|
Time Factors | 9 | 2021 | 40066 | 0.080 |
Why?
|
Ventricular Function, Left | 2 | 2023 | 3930 | 0.080 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2020 | 2771 | 0.080 |
Why?
|
Pneumonectomy | 1 | 2015 | 1128 | 0.080 |
Why?
|
Neoplasms | 1 | 2017 | 22345 | 0.080 |
Why?
|
Carcinoma | 1 | 2019 | 2309 | 0.070 |
Why?
|
Umbelliferones | 1 | 2007 | 13 | 0.070 |
Why?
|
Picornaviridae | 1 | 2007 | 14 | 0.070 |
Why?
|
Adenine Nucleotides | 1 | 2008 | 110 | 0.070 |
Why?
|
Kaplan-Meier Estimate | 2 | 2016 | 6499 | 0.070 |
Why?
|
Hyperthermia, Induced | 1 | 2011 | 414 | 0.070 |
Why?
|
Drug Design | 4 | 2008 | 1042 | 0.070 |
Why?
|
Follow-Up Studies | 9 | 2024 | 39180 | 0.070 |
Why?
|
Histones | 1 | 2018 | 2592 | 0.070 |
Why?
|
Diabetic Angiopathies | 1 | 2012 | 805 | 0.070 |
Why?
|
Molecular Targeted Therapy | 1 | 2018 | 2822 | 0.070 |
Why?
|
Phenanthrolines | 1 | 2007 | 48 | 0.070 |
Why?
|
Knee | 1 | 2009 | 271 | 0.070 |
Why?
|
Lymphocyte Count | 2 | 2019 | 789 | 0.070 |
Why?
|
Candida glabrata | 1 | 2007 | 42 | 0.070 |
Why?
|
Mycobacterium tuberculosis | 3 | 2007 | 1918 | 0.070 |
Why?
|
Biocompatible Materials | 2 | 2006 | 1683 | 0.070 |
Why?
|
Area Under Curve | 2 | 2024 | 1639 | 0.070 |
Why?
|
ROC Curve | 3 | 2024 | 3618 | 0.070 |
Why?
|
Ischemia | 1 | 2015 | 1910 | 0.070 |
Why?
|
Platelet Count | 2 | 2019 | 782 | 0.070 |
Why?
|
Disease Management | 1 | 2017 | 2534 | 0.070 |
Why?
|
Radiosurgery | 1 | 2016 | 1328 | 0.070 |
Why?
|
Endarterectomy, Carotid | 1 | 2011 | 557 | 0.070 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2020 | 2309 | 0.060 |
Why?
|
Venous Thromboembolism | 1 | 2019 | 1882 | 0.060 |
Why?
|
Keto Acids | 1 | 2005 | 32 | 0.060 |
Why?
|
Blotting, Southern | 1 | 2006 | 772 | 0.060 |
Why?
|
Melanoma | 1 | 2024 | 5690 | 0.060 |
Why?
|
Preoperative Period | 2 | 2019 | 566 | 0.060 |
Why?
|
Combined Modality Therapy | 2 | 2020 | 8528 | 0.060 |
Why?
|
Piperazines | 2 | 2006 | 2546 | 0.060 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2006 | 372 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2013 | 2454 | 0.060 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2011 | 1727 | 0.060 |
Why?
|
Nerve Sheath Neoplasms | 1 | 2006 | 169 | 0.060 |
Why?
|
Structure-Activity Relationship | 5 | 2008 | 3054 | 0.060 |
Why?
|
Myocytes, Cardiac | 1 | 2013 | 1670 | 0.060 |
Why?
|
Thermodynamics | 1 | 2006 | 580 | 0.060 |
Why?
|
Reproducibility of Results | 5 | 2023 | 20120 | 0.060 |
Why?
|
Carotid Stenosis | 1 | 2011 | 861 | 0.060 |
Why?
|
Candida albicans | 1 | 2007 | 377 | 0.060 |
Why?
|
Brachytherapy | 1 | 2011 | 1220 | 0.060 |
Why?
|
Enzyme Inhibitors | 2 | 2005 | 3717 | 0.050 |
Why?
|
Decision Making | 1 | 2017 | 3964 | 0.050 |
Why?
|
Phosphonoacetic Acid | 1 | 2003 | 54 | 0.050 |
Why?
|
Polyamines | 1 | 2004 | 130 | 0.050 |
Why?
|
Contrast Media | 1 | 2017 | 5326 | 0.050 |
Why?
|
Anticoagulants | 1 | 2019 | 4862 | 0.050 |
Why?
|
Pyrimidines | 2 | 2006 | 3044 | 0.050 |
Why?
|
Logistic Models | 4 | 2019 | 13261 | 0.050 |
Why?
|
Risk Assessment | 6 | 2020 | 24279 | 0.050 |
Why?
|
Patient Readmission | 1 | 2017 | 3286 | 0.050 |
Why?
|
Cyclodextrins | 1 | 2003 | 62 | 0.050 |
Why?
|
Young Adult | 10 | 2020 | 59852 | 0.050 |
Why?
|
Fusion Proteins, bcr-abl | 1 | 2005 | 430 | 0.050 |
Why?
|
Ribonucleotide Reductases | 1 | 2003 | 75 | 0.050 |
Why?
|
Stroke Volume | 1 | 2017 | 5596 | 0.050 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2012 | 1211 | 0.050 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2006 | 1679 | 0.050 |
Why?
|
Myocardial Ischemia | 1 | 2013 | 2129 | 0.050 |
Why?
|
Adolescent | 7 | 2020 | 88781 | 0.050 |
Why?
|
Bone Transplantation | 2 | 2018 | 920 | 0.050 |
Why?
|
Hemeproteins | 1 | 2002 | 61 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2006 | 723 | 0.050 |
Why?
|
Esters | 1 | 2003 | 214 | 0.050 |
Why?
|
Protoporphyrins | 1 | 2002 | 167 | 0.050 |
Why?
|
Cohort Studies | 6 | 2022 | 41631 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2018 | 10385 | 0.050 |
Why?
|
Postoperative Period | 2 | 2018 | 1816 | 0.050 |
Why?
|
Hexokinase | 2 | 1992 | 125 | 0.050 |
Why?
|
Gene Amplification | 1 | 2006 | 1089 | 0.050 |
Why?
|
Anxiety | 1 | 2016 | 4670 | 0.050 |
Why?
|
Equipment Design | 2 | 2020 | 3485 | 0.050 |
Why?
|
Hypercalcemia | 1 | 2024 | 425 | 0.050 |
Why?
|
Nanostructures | 1 | 2006 | 548 | 0.050 |
Why?
|
Heart Diseases | 1 | 2014 | 2820 | 0.040 |
Why?
|
Triazoles | 1 | 2006 | 897 | 0.040 |
Why?
|
Materials Testing | 2 | 2020 | 868 | 0.040 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2005 | 689 | 0.040 |
Why?
|
Models, Biological | 2 | 2006 | 9441 | 0.040 |
Why?
|
Predictive Value of Tests | 4 | 2020 | 15390 | 0.040 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2017 | 8926 | 0.040 |
Why?
|
Gastrointestinal Stromal Tumors | 1 | 2006 | 616 | 0.040 |
Why?
|
Reference Values | 2 | 2017 | 4909 | 0.040 |
Why?
|
Drug Carriers | 1 | 2004 | 700 | 0.040 |
Why?
|
Protein Structure, Tertiary | 4 | 2007 | 3751 | 0.040 |
Why?
|
Colombia | 1 | 2020 | 287 | 0.040 |
Why?
|
Coated Materials, Biocompatible | 1 | 2021 | 314 | 0.040 |
Why?
|
Lymphoma | 2 | 2019 | 1896 | 0.040 |
Why?
|
Physicians | 1 | 2017 | 4587 | 0.040 |
Why?
|
Albumins | 1 | 2021 | 577 | 0.040 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2006 | 1376 | 0.040 |
Why?
|
Mutation | 2 | 2018 | 30184 | 0.040 |
Why?
|
Recovery of Function | 2 | 2020 | 2965 | 0.040 |
Why?
|
Cell Line | 6 | 2008 | 15542 | 0.040 |
Why?
|
Platelet Function Tests | 1 | 2020 | 275 | 0.040 |
Why?
|
Coronary Angiography | 2 | 2020 | 4494 | 0.040 |
Why?
|
Protein Conformation | 1 | 2006 | 3946 | 0.040 |
Why?
|
Hepacivirus | 1 | 2005 | 1343 | 0.040 |
Why?
|
Vascular Patency | 1 | 2021 | 912 | 0.040 |
Why?
|
Italy | 1 | 2020 | 851 | 0.040 |
Why?
|
Necrosis | 1 | 2022 | 1613 | 0.040 |
Why?
|
Body Mass Index | 1 | 2016 | 13044 | 0.040 |
Why?
|
Arthrodesis | 1 | 2019 | 186 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 11865 | 0.040 |
Why?
|
Swine, Miniature | 1 | 2020 | 971 | 0.040 |
Why?
|
Polyethylene Glycols | 1 | 2003 | 1188 | 0.040 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2012 | 3251 | 0.040 |
Why?
|
Molecular Conformation | 3 | 2003 | 541 | 0.040 |
Why?
|
Apoptosis | 1 | 2013 | 9511 | 0.040 |
Why?
|
Sacrum | 1 | 2019 | 270 | 0.040 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2019 | 345 | 0.030 |
Why?
|
Tomography, Optical Coherence | 2 | 2020 | 2878 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 2 | 2017 | 20667 | 0.030 |
Why?
|
Neoadjuvant Therapy | 2 | 2022 | 2895 | 0.030 |
Why?
|
Aftercare | 1 | 2023 | 911 | 0.030 |
Why?
|
Depression | 1 | 2016 | 8230 | 0.030 |
Why?
|
Binding Sites | 4 | 2007 | 6001 | 0.030 |
Why?
|
Folic Acid | 1 | 2003 | 1338 | 0.030 |
Why?
|
Radiography | 2 | 2019 | 6917 | 0.030 |
Why?
|
Phosphorylation | 2 | 2006 | 8279 | 0.030 |
Why?
|
Florida | 1 | 2017 | 416 | 0.030 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2006 | 2269 | 0.030 |
Why?
|
Fractures, Stress | 1 | 2018 | 202 | 0.030 |
Why?
|
Operating Rooms | 1 | 2022 | 788 | 0.030 |
Why?
|
Climate Change | 1 | 2022 | 509 | 0.030 |
Why?
|
Odds Ratio | 2 | 2019 | 9647 | 0.030 |
Why?
|
Lipopolysaccharides | 1 | 2023 | 2215 | 0.030 |
Why?
|
Embolism, Fat | 1 | 2015 | 46 | 0.030 |
Why?
|
Radiotherapy, Adjuvant | 2 | 2012 | 1775 | 0.030 |
Why?
|
Patients | 1 | 2022 | 910 | 0.030 |
Why?
|
Fracture Fixation | 1 | 2017 | 369 | 0.030 |
Why?
|
Morbidity | 1 | 2020 | 1749 | 0.030 |
Why?
|
Posture | 1 | 2019 | 953 | 0.030 |
Why?
|
Artificial Limbs | 1 | 2016 | 121 | 0.030 |
Why?
|
Pelvis | 1 | 2019 | 738 | 0.030 |
Why?
|
Fracture Healing | 1 | 2017 | 448 | 0.030 |
Why?
|
Decompression, Surgical | 1 | 2019 | 603 | 0.030 |
Why?
|
Drug Resistance | 1 | 2020 | 1591 | 0.030 |
Why?
|
Inhibitory Concentration 50 | 2 | 2006 | 461 | 0.030 |
Why?
|
Fracture Fixation, Intramedullary | 1 | 2016 | 160 | 0.030 |
Why?
|
Cricetinae | 2 | 2008 | 2411 | 0.030 |
Why?
|
Pulmonary Embolism | 2 | 2019 | 2598 | 0.030 |
Why?
|
Factor Analysis, Statistical | 1 | 2016 | 999 | 0.030 |
Why?
|
Models, Animal | 1 | 2020 | 2120 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 3 | 2023 | 36537 | 0.030 |
Why?
|
Treatment Failure | 1 | 2019 | 2653 | 0.030 |
Why?
|
Aortic Valve | 1 | 2023 | 1968 | 0.030 |
Why?
|
Cell Survival | 3 | 2007 | 5747 | 0.030 |
Why?
|
Biopsy, Fine-Needle | 1 | 2018 | 1129 | 0.030 |
Why?
|
Hexosephosphates | 1 | 1992 | 24 | 0.030 |
Why?
|
Accidents, Traffic | 1 | 2018 | 818 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2019 | 21053 | 0.020 |
Why?
|
Myocardial Contraction | 1 | 2017 | 1516 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2020 | 2354 | 0.020 |
Why?
|
Glomerular Filtration Rate | 1 | 2020 | 2233 | 0.020 |
Why?
|
Range of Motion, Articular | 1 | 2018 | 1595 | 0.020 |
Why?
|
Cell Hypoxia | 1 | 2013 | 646 | 0.020 |
Why?
|
Radiotherapy Dosage | 1 | 2018 | 2864 | 0.020 |
Why?
|
Protein Transport | 2 | 2006 | 1937 | 0.020 |
Why?
|
Lymphatic Metastasis | 1 | 2018 | 2882 | 0.020 |
Why?
|
Radiotherapy | 1 | 2017 | 1494 | 0.020 |
Why?
|
Hemoglobins | 1 | 2017 | 1528 | 0.020 |
Why?
|
Multiple Myeloma | 2 | 2019 | 5195 | 0.020 |
Why?
|
Proportional Hazards Models | 2 | 2017 | 12509 | 0.020 |
Why?
|
Microbial Sensitivity Tests | 2 | 2007 | 1971 | 0.020 |
Why?
|
Benzamides | 2 | 2006 | 1376 | 0.020 |
Why?
|
Shoulder Joint | 1 | 2017 | 740 | 0.020 |
Why?
|
Swine | 1 | 2020 | 5986 | 0.020 |
Why?
|
Patient Discharge | 1 | 2023 | 3461 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2018 | 4106 | 0.020 |
Why?
|
Venous Thrombosis | 1 | 2019 | 1327 | 0.020 |
Why?
|
Asymptomatic Diseases | 1 | 2012 | 583 | 0.020 |
Why?
|
Hospitals | 1 | 2023 | 3889 | 0.020 |
Why?
|
Mass Spectrometry | 2 | 2008 | 2194 | 0.020 |
Why?
|
Disability Evaluation | 1 | 2016 | 1820 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2005 | 5693 | 0.020 |
Why?
|
Observer Variation | 1 | 2015 | 2611 | 0.020 |
Why?
|
Aspirin | 1 | 2020 | 3135 | 0.020 |
Why?
|
Diarrhea Viruses, Bovine Viral | 1 | 2008 | 6 | 0.020 |
Why?
|
Tetrazolium Salts | 1 | 2008 | 92 | 0.020 |
Why?
|
Chromatography, Thin Layer | 1 | 2008 | 211 | 0.020 |
Why?
|
Mannich Bases | 1 | 2007 | 2 | 0.020 |
Why?
|
Thrombophlebitis | 1 | 2009 | 286 | 0.020 |
Why?
|
Databases, Factual | 2 | 2017 | 8062 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 2017 | 4858 | 0.020 |
Why?
|
Prevalence | 2 | 2017 | 15833 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2012 | 1185 | 0.020 |
Why?
|
Surgical Wound Dehiscence | 1 | 2009 | 215 | 0.020 |
Why?
|
Upper Extremity | 1 | 2012 | 682 | 0.020 |
Why?
|
Entropy | 1 | 2008 | 208 | 0.020 |
Why?
|
Skin Transplantation | 1 | 2012 | 1097 | 0.020 |
Why?
|
Indicators and Reagents | 1 | 2008 | 456 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2015 | 3595 | 0.020 |
Why?
|
Enterovirus | 1 | 2007 | 69 | 0.020 |
Why?
|
Linear Models | 1 | 2017 | 5876 | 0.020 |
Why?
|
Boston | 1 | 2020 | 9337 | 0.020 |
Why?
|
Magnesium Hydroxide | 1 | 2006 | 9 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2008 | 3673 | 0.020 |
Why?
|
Adsorption | 1 | 2006 | 200 | 0.020 |
Why?
|
Pilot Projects | 1 | 2020 | 8732 | 0.020 |
Why?
|
Animals | 7 | 2020 | 168731 | 0.020 |
Why?
|
Aluminum Hydroxide | 1 | 2006 | 55 | 0.020 |
Why?
|
Carotid Artery Diseases | 1 | 2012 | 869 | 0.020 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2008 | 506 | 0.020 |
Why?
|
Viral Nonstructural Proteins | 1 | 2007 | 226 | 0.020 |
Why?
|
Binding, Competitive | 1 | 2007 | 1140 | 0.020 |
Why?
|
Diabetes Complications | 1 | 2012 | 1316 | 0.020 |
Why?
|
Quantitative Structure-Activity Relationship | 1 | 2005 | 28 | 0.020 |
Why?
|
Isoleucine | 1 | 2005 | 109 | 0.020 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2008 | 720 | 0.020 |
Why?
|
Lumbar Vertebrae | 1 | 2015 | 1874 | 0.020 |
Why?
|
Candida | 1 | 2006 | 172 | 0.020 |
Why?
|
Sciatic Nerve | 1 | 2009 | 624 | 0.020 |
Why?
|
Kidney | 1 | 2020 | 7066 | 0.010 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 2007 | 423 | 0.010 |
Why?
|
Diffusion | 1 | 2006 | 808 | 0.010 |
Why?
|
Spectrum Analysis | 1 | 2007 | 443 | 0.010 |
Why?
|
Skin Neoplasms | 1 | 2024 | 5824 | 0.010 |
Why?
|
Threonine | 1 | 2005 | 272 | 0.010 |
Why?
|
Models, Statistical | 1 | 2019 | 5088 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2013 | 6219 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2018 | 11007 | 0.010 |
Why?
|
Death, Sudden, Cardiac | 1 | 2012 | 1567 | 0.010 |
Why?
|
Surgical Flaps | 1 | 2012 | 1678 | 0.010 |
Why?
|
Pneumonia | 1 | 2015 | 2156 | 0.010 |
Why?
|
Chemistry, Physical | 1 | 2003 | 152 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 2019 | 4352 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2017 | 12056 | 0.010 |
Why?
|
Health Status | 1 | 2016 | 4081 | 0.010 |
Why?
|
Chemical Phenomena | 1 | 2003 | 483 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2018 | 12949 | 0.010 |
Why?
|
Solvents | 1 | 2004 | 300 | 0.010 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2008 | 1332 | 0.010 |
Why?
|
Nucleosides | 1 | 2003 | 130 | 0.010 |
Why?
|
Dogs | 1 | 2007 | 3822 | 0.010 |
Why?
|
Escherichia coli | 2 | 1992 | 4214 | 0.010 |
Why?
|
Oxidative Stress | 1 | 2014 | 3140 | 0.010 |
Why?
|
Cattle | 1 | 2008 | 3800 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2012 | 6832 | 0.010 |
Why?
|
Child | 2 | 2020 | 80499 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2014 | 10730 | 0.010 |
Why?
|
Wound Healing | 1 | 2012 | 2790 | 0.010 |
Why?
|
Molecular Mimicry | 1 | 2002 | 210 | 0.010 |
Why?
|
Surface Properties | 1 | 2004 | 1152 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2018 | 9245 | 0.010 |
Why?
|
Thiazoles | 1 | 2008 | 1529 | 0.010 |
Why?
|
Myocardium | 1 | 2013 | 4763 | 0.010 |
Why?
|
Ligands | 1 | 2007 | 3273 | 0.010 |
Why?
|
Electrocardiography | 1 | 2014 | 6401 | 0.010 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2009 | 3537 | 0.010 |
Why?
|
Recurrence | 1 | 2012 | 8498 | 0.010 |
Why?
|
Stroke | 2 | 2012 | 9747 | 0.010 |
Why?
|
Macromolecular Substances | 1 | 2002 | 1430 | 0.010 |
Why?
|
Age Factors | 1 | 2016 | 18375 | 0.010 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 2 | 1992 | 1724 | 0.010 |
Why?
|
Ultrasonography | 1 | 2012 | 5986 | 0.010 |
Why?
|
Registries | 1 | 2015 | 8293 | 0.010 |
Why?
|
Skin | 1 | 2012 | 4474 | 0.010 |
Why?
|
Bacterial Proteins | 1 | 1991 | 3837 | 0.010 |
Why?
|
Proteins | 1 | 1991 | 5996 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2011 | 8038 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2017 | 26284 | 0.010 |
Why?
|
Protein Binding | 1 | 2007 | 9299 | 0.010 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2008 | 4405 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2012 | 7424 | 0.010 |
Why?
|
Computational Biology | 1 | 2005 | 3558 | 0.010 |
Why?
|
Placenta | 2 | 1992 | 1728 | 0.010 |
Why?
|
Chromatography, Ion Exchange | 1 | 1992 | 289 | 0.010 |
Why?
|
Mice | 2 | 2013 | 81792 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 2012 | 11504 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2006 | 5336 | 0.010 |
Why?
|
Base Sequence | 2 | 1992 | 12402 | 0.010 |
Why?
|
Oxygen | 1 | 2002 | 4242 | 0.010 |
Why?
|
Catalysis | 1 | 1992 | 770 | 0.010 |
Why?
|
Amino Acid Sequence | 2 | 1992 | 13403 | 0.010 |
Why?
|
Blotting, Northern | 1 | 1991 | 1546 | 0.010 |
Why?
|
Molecular Sequence Data | 2 | 1992 | 17595 | 0.000 |
Why?
|
Open Reading Frames | 1 | 1992 | 820 | 0.000 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 1992 | 1526 | 0.000 |
Why?
|
Cell Line, Tumor | 1 | 2003 | 17062 | 0.000 |
Why?
|
Enzyme Activation | 1 | 1992 | 3585 | 0.000 |
Why?
|
Cloning, Molecular | 1 | 1991 | 4165 | 0.000 |
Why?
|
HIV-1 | 1 | 2003 | 6944 | 0.000 |
Why?
|
Blotting, Western | 1 | 1992 | 5019 | 0.000 |
Why?
|
Kinetics | 1 | 1992 | 6272 | 0.000 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 1991 | 3805 | 0.000 |
Why?
|
Recombinant Proteins | 1 | 1992 | 6492 | 0.000 |
Why?
|
DNA | 1 | 1992 | 7200 | 0.000 |
Why?
|
Pregnancy | 1 | 1992 | 30248 | 0.000 |
Why?
|